Search Results

• • 360 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select A prediction model on incident ESKD among individuals with T2D and CKD.

  1

  A prediction model on incident ESKD among individuals with T2D and CKD.

  Authors:Yilu Lin, Hui Shao, Vivian Fonseca, Amanda H. Anderson, Vecihi Batuman, and Lizheng ShiFrom:Journal of Diabetes and Its Complications (Vol. 37, Issue 4) Peer-Reviewed

  Apr. 2023538 words Report

   Abstract Only
• Select The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes.

  2

  The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Comprehensive Metabolic Biomarkers Among Multimorbid Patients With Type 2 Diabetes.

  Authors:Yixue Shao, Charles Stoecker, Dongzhe Hong, Elizabeth Nauman, Vivian Fonseca, Gang Hu, et al.From:Medical Care (Vol. 61, Issue 3) Peer-Reviewed

  Mar. 1, 2023349 words Brief article

   Abstract Only
• Select A prediction model of CKD progression among individuals with type 2 diabetes in the United States.

  3

  A prediction model of CKD progression among individuals with type 2 diabetes in the United States.

  Authors:Yilu Lin, Hui Shao, Vivian Fonseca, Amanda H. Anderson, Vecihi Batuman, and Lizheng ShiFrom:Journal of Diabetes and Its Complications (Vol. 37, Issue 3) Peer-Reviewed

  Mar. 2023502 words Report

   Abstract Only
• Select Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.

  4

  Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use.

  Authors:Peter Rossing, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, et al.From:Diabetes, Obesity and Metabolism (Vol. 25, Issue 2)

  Feb. 2023303 words Report, Brief articl...

   Abstract Only
• Select Front Cover.

  5

  Front Cover.

  Authors:Peter Rossing, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Luis M. Ruilope, et al.From:Diabetes, Obesity and Metabolism (Vol. 25, Issue 2)

  Feb. 202341 words Report, Brief articl...

   Abstract Only
• Select Rising Prediabetes, Undiagnosed Diabetes, and Risk Factors in Young Women.

  6

  Rising Prediabetes, Undiagnosed Diabetes, and Risk Factors in Young Women.

  Authors:Yilin Yoshida, Jia Wang, Yuanhao Zu, Vivian A. Fonseca, and Franck Mauvais-JarvisFrom:American Journal of Preventive Medicine (Vol. 64, Issue 3) Peer-Reviewed

  Mar. 2023400 words Brief article

   Abstract Only
• Select Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease.

  7

  Sex differences in prognostic role of fasting glucose, Oral glucose tolerance, and HbA1c in diabetic cardiovascular disease.

  Authors:Yilin Yoshida, Zhipeng Chen, Robin L. Baudier, Marie Krousel-Wood, Amanda H. Anderson, Vivian A. Fonseca, et al.From:Journal of Diabetes (Vol. 15, Issue 2) Peer-Reviewed

  Feb. 202367 words Report, Brief articl...

   Abstract Only
• Select Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.

  8

  Early intervention and intensive management of patients with diabetes, cardiorenal, and metabolic diseases.

  Authors:Yehuda Handelsman, Javed Butler, George L. Bakris, Ralph A. DeFronzo, Gregg C. Fonarow, Jennifer B. Green, et al.From:Journal of Diabetes and Its Complications (Vol. 37, Issue 2) Peer-Reviewed

  Feb. 2023651 words Disease/Disorder ove...

   Abstract Only
• Select Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.

  9

  Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.

  Authors:Rory J. McCrimmon, Philip Home, Alice Cheng, Francesco Giorgino, Vivian Fonseca, Elisabeth Souhami, et al.From:Diabetes, Obesity and Metabolism (Vol. 24, Issue 12)

  Dec. 2022369 words Report, Brief articl...

   Abstract Only
• Select Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk score.

  10

  Predicting incident heart failure among patients with type 2 diabetes mellitus: The DM-CURE risk score.

  Authors:Yilu Lin, Hui Shao, Lizheng Shi, Amanda H. Anderson, and Vivian FonsecaFrom:Diabetes, Obesity and Metabolism (Vol. 24, Issue 11)

  Nov. 2022392 words Report, Brief articl...

   Abstract Only
• Select Amyloid [beta] (1--42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence.

  11

  Amyloid [beta] (1--42) peptide impairs mitochondrial respiration in primary human brain microvascular endothelial cells: impact of dysglycemia and pre-senescence.

  Authors:Siva S. V. P. Sakamuri, Venkata N. Sure, Xiaoying Wang, Gregory Bix, Vivian A. Fonseca, Ricardo Mostany, et al.From:GeroScience (Vol. 44, Issue 6) Peer-Reviewed

  Dec. 2022314 words Report, Brief articl...

   Abstract Only
• Select The trial to assess chelation therapy 2 (TACT2): Rationale and design.

  12

  The trial to assess chelation therapy 2 (TACT2): Rationale and design.

  Authors:Gervasio A. Lamas, Kevin J. Anstrom, Ana Navas-Acien, Robin Boineau, Hwasoon Kim, Yves Rosenberg, et al.From:American Heart Journal (Vol. 252) Peer-Reviewed

  Oct. 2022583 words Clinical report

   Abstract Only
• Select Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US.

  13

  Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US.

  Authors:Hui Shao, Abdul Jabbar Omar Alsaleh, Terry Dex, Elisheva Lew, and Vivian FonsecaFrom:Diabetes Therapy (Vol. 13, Issue 9) Peer-Reviewed

  Sept. 20225,045 words Report 1620LIntroduction Many people with type 2 diabetes mellitus (T2DM) experience suboptimal glycemic control and require therapy advancement. This cost-effectiveness analysis was conducted to compare iGlarLixi (insulin...
• Select A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.

  14

  A machine learning approach identifies modulators of heart failure hospitalization prevention among patients with type 2 diabetes: A revisit to the ACCORD trial.

  Authors:Hamed Kianmehr, Jingchuan Guo, Yilu Lin, Jing Luo, William Cushman, Lizheng Shi, et al.From:Journal of Diabetes and Its Complications (Vol. 36, Issue 9) Peer-Reviewed

  Sept. 2022608 words Report

   Abstract Only
• Select Progress and change

  15

  Progress and change

  Authors:Vivian Fonseca, Stefano Del Prato, and Raghavendra G. MirmiraFrom:Journal of Diabetes and Its Complications (Vol. 29, Issue 1) Peer-Reviewed

  January-February 201531 words Article

   Abstract Only
• Select Bile Acid Sequestrants for Lipid and Glucose Control

  16

  Bile Acid Sequestrants for Lipid and Glucose Control

  Authors:Bart Staels, Yehuda Handelsman, and Vivian FonsecaFrom:Current Diabetes Reports (Vol. 10, Issue 1)

  Feb. 2010228 words Report

   Abstract Only
• Select Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.

  17

  Economic burden of diabetes-related hypoglycemia on patients, payors, and employers.

  Authors:Lizheng Shi, Vivian Fonseca, and Belinda ChildsFrom:Journal of Diabetes and Its Complications (Vol. 35, Issue 6) Peer-Reviewed

  June 2021364 words Report, Brief articl...

   Abstract Only
• Select Subramaniam B, Pomposelli F, Talmor D, Park KW: Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics

  18

  Subramaniam B, Pomposelli F, Talmor D, Park KW: Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics

  Author:Vivian FonsecaFrom:Diabetes Care (Vol. 28, Issue 11) Peer-Reviewed

  Nov. 2005318 words Brief article Subramaniam B, Pomposelli F, Talmor D, Park KW: Perioperative and long-term morbidity and mortality after above-knee and below-knee amputations in diabetics and nondiabetics. Anesth Analg 100:1241-1247 Findings. This...
• Select Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E: the post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart

  19

  Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E: the post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart

  Author:Vivian FonsecaFrom:Diabetes Care (Vol. 27, Issue 7) Peer-Reviewed

  July 2004294 words Brief article Ceriello A, Cavarape A, Martinelli L, Da Ros R, Marra G, Quagliaro L, Piconi L, Assaloni R, Motz E: The post-prandial state in type 2 diabetes and endothelial dysfunction: effects of insulin aspart. Diabet Med...
• Select Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlof B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S: Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

  20

  Carr AA, Kowey PR, Devereux RB, Brenner BM, Dahlof B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S: Hospitalizations for new heart failure among subjects with diabetes mellitus in the RENAAL and LIFE studies

  Author:Vivian FonsecaFrom:Diabetes Care (Vol. 29, Issue 5) Peer-Reviewed

  May 2006412 words Article 1360LCarr AA, Kowey PR, Devereux RB, Brenner BM, Dahlof B, Ibsen H, Lindholm LH, Lyle PA, Snapinn SM, Zhang Z, Edelman JM, Shahinfar S: Hospitalizations for new heart failure among subjects with diabetes mellitus in the...